Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs

Go back to Assembly Biosciences Regains Worldwide Rights to Microbiome Gastrointestinal Development Programs
(NASDAQ: ASMB) Delayed: 35.18 +1.55 (4.61%)
Previous Close $33.63    52 Week High $14.50 
Open $34.12    52 Week Low $4.33 
Day High $35.33    P/E N/A 
Day Low $33.43    EPS $0.00 
Volume 301,100